GLADIUS PHARMACEUTICALS CORP

Profile

Company Names

GLADIUS PHARMACEUTICALS CORP

Addresses

2711 CENTERVILLE ROAD, SUITE 400, COUNTY NEWCASTLE, WILMINGTON, DE 19808

2711 CENTERVILLE RD., SUITE 400, WILMINGTON, DE 19808

Phone Numbers

514-213-4456

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$3,750,240.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-11-14 
$3,022,400.00 
$3,022,400.00 
$0.00 
Equity, Debt 
1
2015-06-22 
$727,840.00 
$727,840.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
ATKIN 
EXECUTIVE OFFICER, DIRECTOR
GLADIUS PHARMACEUTICALS CORP   |  ORTHO REGENERATIVE TECHNOLOGIES INC.
NATHALIE 
 
CHAURET 
DIRECTOR
GLADIUS PHARMACEUTICALS CORP
JENS 
 
ECKSTEIN 
DIRECTOR
ASCENT THERAPEUTICS INC   |  ALIOS BIOPHARMA INC   |  THRASOS INNOVATION INC.   |  DECIBEL THERAPEUTICS, INC.   |  PALLEON PHARMA INC.   |  PALLEON PHARMACEUTICALS INC.   |  GLADIUS PHARMACEUTICALS CORP   |  AEOVIAN PHARMACEUTICALS, INC.   |  SAMSARA THERAPEUTICS INC.   |  BOSWELL, INC.
DANIEL 
 
HETU 
DIRECTOR
THRASOS INNOVATION INC.   |  GLADIUS PHARMACEUTICALS CORP   |  KALGENE PHAMACEUTICALS INC.
LARRY 
 
SUTTON 
DIRECTOR
GLADIUS PHARMACEUTICALS CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-11-14 
2015-06-30
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2015-06-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#